Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
CA‐549: A new tumor marker for patients with advanced breast cancer
Laurence Demers
, Harold Harvey
, Jerry D. Glenn
, Pramod K. Gaur
Department of Pathology and Laboratory Medicine
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CA‐549: A new tumor marker for patients with advanced breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
Advanced Breast Cancer
100%
Tumor Marker
100%
New Tumor
100%
Breast
20%
Postmenopausal Women
20%
Lung Cancer
20%
Adjuvant Therapy
20%
Colorectal Cancer
20%
Advanced Stage
20%
IgG1
20%
Serum Levels
20%
Treatment Evaluation
20%
Remission
20%
Ovarian Cancer
20%
Circulating Levels
20%
Murine Antibody
20%
Patients with Cancer
20%
Circulating Antigen
20%
Circulating Markers
20%
Benign Breast Disease
20%
Immunology and Microbiology
Postmenopause
100%
Monoclonal Antibody
100%
Immunoglobulin G1
100%
Blood Level
100%
Tumor Antigen
100%
Biochemistry, Genetics and Molecular Biology
Postmenopause
100%
Tumor Marker
100%
Blood Level
100%
Monoclonal Antibody
100%
Tumor Antigen
100%
Medicine and Dentistry
Breast Cancer
100%
Tumor Marker
100%
Monoclonal Antibody
14%
Adjuvant Therapy
14%
Immunoglobulin G1
14%
Lung Cancer
14%
Sensitivity and Specificity
14%
Postmenopause
14%
Tumor Antigen
14%
Ovarian Cancer
14%
Radioactive Tracer
14%
Breast Disease
14%
Colorectal Carcinoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Tumor Marker
100%
Ovary Cancer
14%
Immunoglobulin G1
14%
Lung Cancer
14%
Tracer
14%
Remission
14%
Monoclonal Antibody
14%
Colorectal Carcinoma
14%
Tumor Antigen
14%
Breast Disease
14%
Nursing and Health Professions
Breast Disease
14%
Tumor Antigen
14%
Immunoglobulin G1
14%
Immunoradiometric Assay
14%